TP53 and adrenal cortex carcinoma: In Brazil, a familial low-penetrance (9.9%) TP53 variant (R337H) contributes to increased ACC development, resulting in the incidence of ACC being nearly 3 to 4 times the global rate at 0.29 to 0.42 per 100,000 [35].